Arkolith/Insider Trading/SUPN/Form 4

Dec Timothy C

Senior Vice-President & CFOSUPERNUS PHARMACEUTICALS, INC. (SUPN) · full profile →Form 4 · filed Feb 25, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Grant(A)500—$03K
Feb 24, 2026Tax withholding(F)2K$50.86$78K4K
Feb 24, 2026Grant(A)3K—$05K
Feb 24, 2026Grant(A)1K—$03K
Feb 24, 2026Tax withholding(F)603$51.35$31K2K
Feb 24, 2026Tax withholding(F)242$50.86$12K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2026Disposed to issuer(D)1K—$03K
Feb 24, 2026Disposed to issuer(D)3K—$06K
Feb 24, 2026Disposed to issuer(D)500—$00

Transaction Codes

A
Grant / award
F
Shares withheld for taxes
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001194020-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML